From July 1, 2023 to September 30, 2023, the company has repurchased 122,200 shares, representing 0.27% for ¥392.94 million. With this, the company has completed the repurchase of 314,600 shares, representing 0.68% for ¥949.81 million under the buyback announced on May 8, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3,190 JPY | -0.93% | -12.72% | +3.24% |
08/05 | Japanese Shares Swing to Red Amid Profit-Taking, US Rate Cut Uncertainty | MT |
08/05 | Kissei Pharmaceutical's Attributable Profit Jumps 6% in Fiscal 2023; Shares Tumble 11% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.24% | 918M | |
+8.05% | 72.03B | |
-11.95% | 5.14B | |
+51.87% | 4.6B | |
+3.92% | 3.96B | |
-14.26% | 2.5B | |
+20.42% | 2.43B | |
-23.94% | 2.32B | |
+20.02% | 2.18B | |
+3.66% | 1.72B |
- Stock Market
- Equities
- 4547 Stock
- News Kissei Pharmaceutical Co., Ltd.
- Tranche Update on Kissei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 8, 2023.